tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Patrick Dolezal, 4 are a BUY (80%), 1 are a HOLD (20%).
Analyst Patrick Dolezal, currently employed at LIFESCI, carries an average stock price target met ratio of 33.33% that have a potential upside of 11.93% achieved within 45 days.
Patrick Dolezal’s has documented 10 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LRMR, Larimar Therapeutics at 25-Jul-2023.
Analyst best performing recommendations are on LRMR (LARIMAR THERAPEUTICS).
The best stock recommendation documented was for LRMR (LARIMAR THERAPEUTICS) at 2/16/2022. The price target of $3 was fulfilled within 82 days with a profit of $0.94 (23.86%) receiving and performance score of 2.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 03-Sep-2025
$22.5
$0.86 (3.97%)
$20
11 months 18 days ago
(20-Nov-2025)
3/3 (100%)
$-0.44 (-1.92%)
10
Hold Since 05-Nov-2025
1 years 2 days ago
(05-Nov-2025)
34/34 (100%)
$9.61 (102.34%)
366
Buy Since 06-Feb-2024
$20
$-1.64 (-7.58%)
$20
1 years 10 days ago
(28-Oct-2025)
4/5 (80%)
$1.41 (7.58%)
278
Buy Since 18-Jul-2025
$20
$-1.64 (-7.58%)
1 years 15 days ago
(23-Oct-2025)
2/2 (100%)
$1.44 (7.76%)
71
Buy Since 30-Jun-2020
$20
$-1.64 (-7.58%)
$24
1 years 15 days ago
(23-Oct-2025)
10/18 (55.56%)
$1.44 (7.76%)
392
What Year was the first public recommendation made by Patrick Dolezal?
